New York, NY -- (SBWIRE) -- 05/03/2021 -- Increasing application of HLA typing in disease diagnosis, increasing number of organ transplantation procedures performed globally, and rising prevalence of chronic diseases are key factors driving market growth

HLA Typing for Transplant Market Size – USD 701.92 Million in 2020, Market Growth – at a CAGR of 7.0%, Market Trends – Rapid technological advancements in molecular assays

The global HLA typing for transplant market size is expected to reach USD 1,206.02 Million by 2028 at a CAGR of 7.0%, according to the latest report by Reports and Data. Increasing prevalence of infectious diseases, rising number of transplant procedures, and growing investment in Human Leukocyte Antigen research are key factors expected to drive market revenue growth over the forecast period. In addition, increasing need for organ transplants due to rising incidence of organ failure due to unhealthy lifestyle and eating habits, and excessive alcohol consumption and drug abuse are other key factors driving revenue growth of the market.

Human Leukocyte Antigen (HLA) typing is primarily carried out to assess immune compatibility of donors and recipient for bone marrow or cord blood transplants. HLA molecules are major molecules that initiate graft rejection and have been widely studied in transplantation biology. HLA typing and matching offers numerous benefits in organ transplantation such as better graft function, longer graft survival, reduced chances of graft rejection, and increased possibility of reduced immunosuppression. Technological advancement in molecular diagnostics have enabled HLA typing to offer more accurate results based on the identification of differences in HLA genes. This is expected to drive revenue growth of the market over the forecast period.

Rising funding and private-public collaboration to boost the scope of HLA research, increasing global burden of infectious diseases, and rapidly growing geriatric population across the globe are key factors expected to drive revenue growth of the market over the forecast period. Rapid shift from serological assays to gene-based HLA typing is expected to further contribute to revenue growth of the market over the forecast period. However, high costs associated with NGS and PCR systems and equipment and unfavorable reimbursement policies regarding organ transplant is expected to restrain market growth to a certain extent over the forecast period.

Key companies in the market include: Thermo Fisher Scientific, Inc., QIAGEN N.V., Illumina, Inc., CareDx, Inc., Immucor, Inc., Bio-Rad Laboratories, Inc., F. Hoffman-La Roche Ltd., Hologic, Inc., Luminex, Biofortuna, Takara Bio, and Omixon, among others.

Get a Free Sample now@ https://www.reportsanddata.com/sample-enquiry-form/3976

Some Key Highlights From the Report:

-Molecular assays segment is expected to register significant revenue growth over the forecast period owing to increasing advantages of PCR-based molecular assays and growing application of real-time PCR (RT-PCR) in research and diagnostic laboratories.

-Instruments segment is expected to register rapid revenue CAGR over the forecast period owing to their enhanced functions and cost-effectiveness. Additionally, development of new technologies has led to production of advanced instruments with longer shelf life and higher accuracy and this is expected to further drive revenue growth of this segment over the forecast period.

-Diagnostic segment is expected to register considerable revenue growth over the forecast period owing to increasing use of HLA typing to diagnose rare and chronic disorders and in preimplantation genetic diagnosis.
Hospitals segment revenue is expected to expand considerably over the forecast period owing to increasing number of patients, rising incidence of chronic and lifestyle-induced diseases, and growing number of organ transplants performed in hospitals.

-North America accounted for a revenue share of 37.1% in the global market in 2020 and is expected to register significant revenue growth over the forecast period owing to increasing investment in HLA research, rapid advancement in transplant technologies, rising incidence of chronic illnesses, and presence of developed healthcare system in the region.

In September 2020, Omixon, which is global leader in molecular diagnostics, launched OmniType, an 11-locus multiplex HLA genotyping assay and software that can be used with the Illumina sequencing platforms.

Request for Customization @ https://www.reportsanddata.com/request-customization-form/3976

For the purpose of this report, Reports and Data has segmented the global HLA typing for transplant market based on technology, product, application, end-use, and region:

Technology Outlook (Revenue, USD Million; 2018-2028)

Molecular Assay Technologies
PCR-Based Molecular Assays
Real-time PCR
Sequence-specific Primer-PCR
Sequence-specific Oligonucleotide-PCR
Other PCR-based Molecular Assays
Sequencing-based Molecular Assays
Sanger Sequencing
Next-generation Sequencing
Other Sequencing-based Molecular Assays
Non-molecular Assay Technologies

Product Outlook (Revenue, USD Million; 2018-2028)

Instrument
Reagents
Services
Application Outlook (Revenue, USD Million; 2018-2028)

Diagnostic Applications
Antibody Screening
Chimerism Monitoring
Others
Research Applications

End-use Outlook (Revenue, USD Million; 2018-2028)

Hospitals
Diagnostic Labs
Academic & Research Institutes

Regional Outlook (Revenue, USD Million; 2018-2028)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Ask for discount @ https://www.reportsanddata.com/discount-enquiry-form/3976

Table of Content:

Chapter 1 HLA Typing for Transplant Market: Methodology And Scope

1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and forecast timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased database
1.4.2 Internal database
1.4.3 Secondary sources
1.4.4 Primary Research
1.5 Information or Data Analysis
1.5.1 Data analysis models
1.6 Market Formulation & Validation
1.7 Objectives
1.7.1 Objective 1
1.7.2 Objective 2

Chapter 2 HLA Typing for Transplant Market: Executive Summary

2.1 Market Summary, 2021

Chapter 3 HLA Typing for Transplant Market: Industry Outlook

3.1 Industry Pyramid Analysis
3.2 Market Segmentation & Scope
3.2.1 Market drivers analysis
3.2.1.1 Increasing use of HLA typing in clinical diagnostics
Continue….

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/hla-typing-for-transplant-market

In conclusion, the HLA Typing for Transplant Market report is a reliable source for accessing the Market data that will exponentially accelerate your business. The report provides the principal locale, economic scenarios with the item value, benefit, supply, limit, generation, request, Market development rate, and figure and so on. Besides, the report presents a new task SWOT analysis, speculation attainability investigation, and venture return investigation.

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyse consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.